XML 40 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Stock-Based Compensation Expense

The following table presents stock-based compensation expense in the Company’s condensed consolidated statements of comprehensive income (loss):

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

(Amounts in thousands)

 

Cost of goods sold

 

$

396

 

 

$

393

 

 

$

1,498

 

 

$

1,506

 

Research and development

 

 

887

 

 

 

700

 

 

 

2,335

 

 

 

2,095

 

Selling, general and administrative(1)

 

 

21,772

 

 

 

5,280

 

 

 

37,878

 

 

 

15,509

 

Total stock-based compensation

 

$

23,055

 

 

$

6,373

 

 

$

41,711

 

 

$

19,110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
Selling, general and administrative stock-based compensation for the three and nine months ended September 30, 2024 includes $17.4 million and $22.4 million of expense related to the Equity Modification discussed above.
Summary of Option Activity

Information regarding option activity for the nine months ended September 30, 2024 under the Plans is summarized below:

 

 

 

Shares

 

 

Weighted
average
exercise
price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value
(in Thousands)

 

Options outstanding at December 31, 2023

 

 

649,130

 

 

$

85.97

 

 

 

 

 

 

 

Granted

 

 

77,014

 

 

$

175.60

 

 

 

 

 

 

 

Exercised

 

 

(43,725

)

 

$

54.11

 

 

 

 

 

 

 

Forfeited/expired/cancelled(1)

 

 

(32,027

)

 

$

195.78

 

 

 

 

 

 

 

Options outstanding at September 30, 2024

 

 

650,392

 

 

$

93.31

 

 

 

 

 

 

 

Options exercisable at September 30, 2024

 

 

398,851

 

 

$

76.47

 

 

 

 

 

 

 

Vested and expected to vest at September 30, 2024(2)

 

 

644,688

 

 

$

92.66

 

 

 

5.31

 

 

$

43,311

 

 

(1)
Includes 13,057 options forfeited pursuant to the 2024 Award Amendment discussed above under “Chief Executive Officer Accounting Modifications”.
(2)
Represents the number of vested options as of September 30, 2024 plus the number of unvested options expected to vest as of September 30, 2024 based on the unvested outstanding options at September 30, 2024 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.
Summary of Restricted Stock Unit Activity Information regarding stock unit activity, which includes activity for restricted stock units and performance stock units, for the nine months ended September 30, 2024 under the Plans is summarized below:

 

 

 

Shares

 

 

Weighted Average
Grant Date
Fair Value

 

 

Unvested at December 31, 2023

 

 

474,320

 

 

$

155.59

 

 

Awarded

 

 

221,584

 

 

$

180.02

 

 

Vested(1)

 

 

(137,072

)

 

$

144.80

 

 

Forfeited/cancelled(2)

 

 

(82,452

)

 

$

190.45

 

 

Unvested at September 30, 2024

 

 

476,380

 

 

$

164.04

 

 

Vested and expected to vest at September 30, 2024(3)

 

 

415,171

 

 

$

162.37

 

 

 

(1)
Includes 1,462 stock units that had vested but not settled as of September 30, 2024.
(2)
Includes 13,146 RSUs and 6,573 PSUs forfeited pursuant to the 2024 Award Amendment discussed above under ”Chief Executive Officer Accounting Modifications”.
(3)
Represents the number of vested stock units as of September 30, 2024 plus the number of unvested stock units expected to vest as of September 30, 2024 based on the unvested outstanding stock units at September 30, 2024 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.